---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047149"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:58:05.204955+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Ensysce stockholders approve reverse stock split authorization and director elections at annual meeting

## Summary
- Approved issuance of shares/warrants to investors: 3,102,053 for, 210,141 against (3,995,063 broker non-votes).
- Authorized reverse stock split with ratio range 1-for-10 to 1-for-40; board sets exact ratio: 4,561,369 for, 1,989,571 against.
- Elected Class III directors Dr. Lynn Kirkpatrick, Dr. Adam Levin, and Mr. Steve Martin (each >2M votes for).
- Ratified Moss Adams LLP as auditor for FY 2024: 5,978,860 for, 259,207 against, 1,250,026 abstentions.
- Fifth proposal to adjourn meeting if needed was not voted on.

## SEC filing metadata
- accession: 0001493152-24-047149
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315224047149/0001493152-24-047149-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315224047149/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047149
- JSON: https://secwatch.observer/filing/0001493152-24-047149.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047149.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.